Literature DB >> 26296146

PREVALENCE OF THE COMPLEMENT FACTOR H AND GSTM1 GENES POLYMORPHISMS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY.

Marilita M Moschos1, Maria Gazouli, Zisis Gatzioufas, Dimitrios Brouzas, Nikolaos Nomikarios, Sobha Sivaprasad, Panagiotis Mitropoulos, Irini P Chatziralli.   

Abstract

PURPOSE: The purpose of our study was to investigate the potential association between the complement factor H (CFH) (rs3753394, rs800292, rs2284664, rs1329428, and rs1065489) and GSTM1 gene polymorphisms, and central serous chorioretinopathy (CSCR) susceptibility in a well-defined Greek cohort.
METHODS: We enrolled a case-control study in a Greek population with 41 cases and 78 controls. Five milliliters of peripheral blood was collected from each participant, and DNA was extracted using the PureLink Genomic DNA kit. The CFH (rs3753394, rs800292, rs2284664, rs1329428, and rs1065489) single nucleotide polymorphisms and GSTM1 polymorphism were tested using polymerase chain reaction assays.
RESULTS: Between CSCR (n = 41) cases and controls (n = 78), the TT rs3753394, GG rs1329428, and TT rs1065489 genotypes' frequencies of the CFH gene were found to be significantly associated with risk of CSCR. The genotype frequency of the CFH rs2284664, rs800292, and of the GSTM1 gene polymorphisms was not found to be significantly associated with CSCR.
CONCLUSION: Our results demonstrated a significant association between CSCR and single nucleotide polymorphisms in the CFH gene (rs3753394, rs1329428, and rs1065489), suggesting that disturbances in choroidal vasculature, through intercorrelation with adrenomedullin, play a significant role in CSCR pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26296146     DOI: 10.1097/IAE.0000000000000693

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  14 in total

1.  Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy.

Authors:  Dandan Linghu; Hui Xu; Zhiqiao Liang; Tingting Gao; Zhaojun Lin; Xiaoxin Li; Lvzhen Huang; Mingwei Zhao
Journal:  Int Ophthalmol       Date:  2020-01-10       Impact factor: 2.031

2.  Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study.

Authors:  Rosa L Schellevis; Elon H C van Dijk; Myrte B Breukink; Lebriz Altay; Bjorn Bakker; Bobby P C Koeleman; Lambertus A Kiemeney; Dorine W Swinkels; Jan E E Keunen; Sascha Fauser; Carel B Hoyng; Anneke I den Hollander; Camiel J F Boon; Eiko K de Jong
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

3.  Association of central serous chorioretinopathy with single nucleotide polymorphisms in complement factor H gene in Iranian population.

Authors:  Reza Karkhaneh; Mohsen Toufighi; Akbar Amirfiroozy; Aliasghar Ahmad-Raji; Oveis Ahmadzadeh; Alborz Mahdavi; Morteza Naderan
Journal:  Eye (Lond)       Date:  2021-05-11       Impact factor: 3.775

4.  Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.

Authors:  Laura Kowalczuk; Alexandre Matet; Marianne Dor; Nasim Bararpour; Alejandra Daruich; Ali Dirani; Francine Behar-Cohen; Aurélien Thomas; Natacha Turck
Journal:  Transl Vis Sci Technol       Date:  2018-01-18       Impact factor: 3.283

5.  Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy.

Authors:  Muhammet Kazim Erol; Ayse Balkarli; Ozgur Yucel; Yusuf Akar; Berna Dogan; Elcin Suren
Journal:  Ther Clin Risk Manag       Date:  2017-07-28       Impact factor: 2.423

6.  CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy.

Authors:  Yoshikatsu Hosoda; Munemitsu Yoshikawa; Masahiro Miyake; Yasuharu Tabara; Jeeyun Ahn; Se Joon Woo; Shigeru Honda; Yoichi Sakurada; Chieko Shiragami; Hideo Nakanishi; Akio Oishi; Sotaro Ooto; Akiko Miki; Tomohiro Iida; Hiroyuki Iijima; Makoto Nakamura; Chiea Chuen Khor; Tien Yin Wong; Kyuyoung Song; Kyu Hyung Park; Ryo Yamada; Fumihiko Matsuda; Akitaka Tsujikawa; Kenji Yamashiro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

Review 7.  Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds.

Authors:  Kenji Yamashiro; Yoshikatsu Hosoda; Masahiro Miyake; Sotaro Ooto; Akitaka Tsujikawa
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

8.  Systemic complement activation in central serous chorioretinopathy.

Authors:  Elon H C van Dijk; Roula Tsonaka; Ngaisah Klar-Mohamad; Diana Wouters; Aiko P J de Vries; Eiko K de Jong; Cees van Kooten; Camiel J F Boon
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

Review 9.  Biomarkers for central serous chorioretinopathy.

Authors:  Gideon Nkrumah; Manuel Paez-Escamilla; Sumit Randhir Singh; Mohammed Abdul Rasheed; Dmitri Maltsev; Abhilash Guduru; Jay Chhablani
Journal:  Ther Adv Ophthalmol       Date:  2020-08-24

Review 10.  Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature.

Authors:  Irini Chatziralli; Aikaterini Vlachodimitropoulou; Chrysoula Daoula; Christina Vrettou; Eleni Galani; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Int J Retina Vitreous       Date:  2018-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.